Company intelligence / Profile preview

FineTech Laboratories

Haifa, Israel

Ownership: Private
Employees: ~80
Development stage: Other

Overview

FineTech Pharmaceutical is an Israel-based developer and manufacturer of complex active pharmaceutical ingredients (APIs) for the global pharmaceutical industry. Founded in 1990, the company specializes in high-potency APIs (HPAPIs), prostaglandins, and other synthetically challenging molecules. FineTech provides services ranging from process development and scale-up to commercial-scale GMP manufacturing. In 2011, the company was acquired by OPKO Health, where it continues to operate as a key technical and manufacturing hub. Its expertise in synthetic organic chemistry supports both generic and branded drug development across multiple therapeutic areas.

Therapeutic areas: OncologyCardiovascularOphthalmologyDermatology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on FineTech Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FineTech Laboratories.

Explore the full profile